HMG CoA reductase expression as a prognostic factor in Korean patients with breast cancer: A retrospective study

There are many preclinical and epidemiological reports suggesting a correlation between 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoAR) or HMG-CoAR inhibitor (statin) treatment and prognosis in breast cancer. This study aimed to investigate the expression of HMG-CoAR in Korean patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyojeong, Seol, Young Mi, Choi, Young Jin, Shin, Ho-Jin, Chung, Joo Seop, Shin, Nari, Kim, Ahrong, Kim, Jee Yeon, Kim, Keun Young, Bae, Youngtae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456116/
https://www.ncbi.nlm.nih.gov/pubmed/30921201
http://dx.doi.org/10.1097/MD.0000000000014968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456116/
https://www.ncbi.nlm.nih.gov/pubmed/30921201
http://dx.doi.org/10.1097/MD.0000000000014968

Ejemplares similares